SMis 9th annual Controlled Release
|Event Date/Time: Mar 28, 2012||End Date/Time: Mar 28, 2012|
|Early Registration Date: Dec 17, 2011|
New for 2012, Lundbeck showcase how to effectively utilise in silico tools from discovery to the clinic.
This is the perfect opportunity to network with key decision makers, key experts and your peers in the field to gain a focused overview of the key developments from 2011 and 2012.
Critical challenges being addressed include:
â€¢ Oral delivery of peptides and proteins, including GLP-1 analogues and insulin
â€¢ Improving oral, lipid-based formulations
â€¢ Optimising in vivo dissolution rate kinetics
â€¢ Delivering CNS-targeted biologics
Hear addresses from:
â€¢ Mario Maio, Director of Formulation & Process Development, Merck Serono
â€¢ Mostafa Nakach, Head of the Pharmaceutical Engineering Group, Sanofi-Aventis
â€¢ Elaine Merisko-Liversidge, Senior Director, Alkermes
â€¢ Karin Liltorp, Director, Preformulation, Lundbeck